Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Magdalena Meffert"'
Autor:
Thomas Menzel, Hartmut Kirchner, Sabine Casper, Jens Atzpodien, Martin Hadam, Alfred Körfer, Axel Schomburg, Hubert Poliwoda, Iris Dallmann, Magdalena Meffert
Publikováno v:
Cancer Biotherapy. 8:199-212
High dose interleukin-2 alone or in combination with lymphokine activated killer (LAK) cells has demonstrated antitumor activity in a variety of malignant diseases. The currently formulated recombinant human interleukin-2 (IL-2) has limited solubilit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e3acfcd8be9a2de4c35af7b36700c82
https://doi.org/10.1089/cbr.1993.8.199
https://doi.org/10.1089/cbr.1993.8.199
Publikováno v:
Cancer biotherapyradiopharmaceuticals. 12(3)
Human recombinant interleukin-2 (rIL-2) induced interferon-gamma (IFN-gamma) release in vivo was studied in 16 renal cell carcinoma patients treated with low-dose s.c. rIL-2. The s.c. administration of rIL-2 resulted in a significant increase in circ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c45304a21790298293ef4c537217510
https://pubmed.ncbi.nlm.nih.gov/10851461
https://pubmed.ncbi.nlm.nih.gov/10851461
Autor:
Enrique Lopez Hänninen, Jens Grosse, Magdalena Meffert, Jan Buer, Iris Dallmann, Robert Hilse, Duensing S, Jens Atzpodien, Hartmut Kirchner, Axel Schomburg, Thomas Menzel, Hubert Poliwoda, Markus Deckert, Stefanie Vocke
Publikováno v:
Cancer biotherapy. 9(4)
Serum concentrations of Interleukin-6 (IL-6) were determined in renal cell carcinoma patients treated with low-dose subcutaneous human recombinant interleukin-2 (rIL-2). In all patients, administration of rIL-2 resulted in a significant increase in I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::387f9bbedb0e5cb33545b5069a6c340f
https://pubmed.ncbi.nlm.nih.gov/7719378
https://pubmed.ncbi.nlm.nih.gov/7719378